In the dupilumab trials, do patients treated with this agent respond predictably in terms of amelioration of specific symptoms—itch, redness, appearance—and how long does it take to see treatment response?
Presenter
Clinical Assistant Professor of Dermatology and Pediatrics
Feinberg School of Medicine
Northwestern University
Chicago, Illinois